Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Antimicrobial Agents and Chemotherapy
|
April 27, 2021
External Evaluation of Two Pediatric Population Pharmacokinetics Models of Oral Trimethoprim and Sulfamethoxazole
Yi Shuan S Wu, Michael Cohen-Wolkowiez, Christoph P Hornik, et al.
Clinical Pharmacokinetics
|
July 2, 2024
Characterizing Enoxaparin's Population Pharmacokinetics to Guide Dose Individualization in the Pediatric Population
Fernando O Carreño, Jacqueline G Gerhart, Victória E Helfer, et al.
Pharmacotherapy
|
May 24, 2022
Leveraging physiologically based pharmacokinetic modeling to optimize dosing for lopinavir/ritonavir with rifampin in pediatric patients
Sara N Salerno, Edmund V Capparelli, Helen McIlleron, et al.
Clinical Pharmacokinetics
|
February 28, 2019
The Population Pharmacokinetics of High-Dose Methotrexate in Infants with Acute Lymphoblastic Leukemia Highlight the Need for Bedside Individualized Dose Adjustment: A Report from the Children's Oncology Group
Ryan J Beechinor, Patrick A Thompson, Michael F Hwang, et al.
Journal of Pharmaceutical Sciences
|
May 1, 1979
Anti-inflammatory activity of sesquiterpene lactones and related compounds
I H Hall, K H Lee, C O Starnes, et al.
Clinical Pharmacology and Therapeutics
|
July 22, 2020
Physiologically-Based Pharmacokinetic Modeling Characterizes the CYP3A-Mediated Drug-Drug Interaction Between Fluconazole and Sildenafil in Infants
Sara N Salerno, Andrea Edginton, Jacqueline G Gerhart, et al.
Clinical Pharmacology and Therapeutics
|
April 22, 2022
Use of Real-World Data and Physiologically-Based Pharmacokinetic Modeling to Characterize Enoxaparin Disposition in Children With Obesity
Jacqueline G Gerhart, Fernando O Carreño, Matthew Shane Loop, et al.
Clinical Pharmacokinetics
|
October 7, 2021
Development and Evaluation of a Virtual Population of Children with Obesity for Physiologically Based Pharmacokinetic Modeling
Jacqueline G Gerhart, Fernando O Carreño, Andrea N Edginton, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
May 2, 2022
Use of physiologically-based pharmacokinetic modeling to inform dosing of the opioid analgesics fentanyl and methadone in children with obesity
Jacqueline G Gerhart, Fernando O Carreño, Jennifer L Ford, et al.
Clinical and Translational Science
|
April 24, 2020
Population Pharmacokinetics of Metoclopramide in Infants, Children, and Adolescents
Shufan Ge, Susan R Mendley, Jacqueline G Gerhart, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Antimicrobial Agents and Chemotherapy
|
April 27, 2021
External Evaluation of Two Pediatric Population Pharmacokinetics Models of Oral Trimethoprim and Sulfamethoxazole
Yi Shuan S Wu, Michael Cohen-Wolkowiez, Christoph P Hornik, et al.
Clinical Pharmacokinetics
|
July 2, 2024
Characterizing Enoxaparin's Population Pharmacokinetics to Guide Dose Individualization in the Pediatric Population
Fernando O Carreño, Jacqueline G Gerhart, Victória E Helfer, et al.
Pharmacotherapy
|
May 24, 2022
Leveraging physiologically based pharmacokinetic modeling to optimize dosing for lopinavir/ritonavir with rifampin in pediatric patients
Sara N Salerno, Edmund V Capparelli, Helen McIlleron, et al.
Clinical Pharmacokinetics
|
February 28, 2019
The Population Pharmacokinetics of High-Dose Methotrexate in Infants with Acute Lymphoblastic Leukemia Highlight the Need for Bedside Individualized Dose Adjustment: A Report from the Children's Oncology Group
Ryan J Beechinor, Patrick A Thompson, Michael F Hwang, et al.
Journal of Pharmaceutical Sciences
|
May 1, 1979
Anti-inflammatory activity of sesquiterpene lactones and related compounds
I H Hall, K H Lee, C O Starnes, et al.
Clinical Pharmacology and Therapeutics
|
July 22, 2020
Physiologically-Based Pharmacokinetic Modeling Characterizes the CYP3A-Mediated Drug-Drug Interaction Between Fluconazole and Sildenafil in Infants
Sara N Salerno, Andrea Edginton, Jacqueline G Gerhart, et al.
Clinical Pharmacology and Therapeutics
|
April 22, 2022
Use of Real-World Data and Physiologically-Based Pharmacokinetic Modeling to Characterize Enoxaparin Disposition in Children With Obesity
Jacqueline G Gerhart, Fernando O Carreño, Matthew Shane Loop, et al.
Clinical Pharmacokinetics
|
October 7, 2021
Development and Evaluation of a Virtual Population of Children with Obesity for Physiologically Based Pharmacokinetic Modeling
Jacqueline G Gerhart, Fernando O Carreño, Andrea N Edginton, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
May 2, 2022
Use of physiologically-based pharmacokinetic modeling to inform dosing of the opioid analgesics fentanyl and methadone in children with obesity
Jacqueline G Gerhart, Fernando O Carreño, Jennifer L Ford, et al.
Clinical and Translational Science
|
April 24, 2020
Population Pharmacokinetics of Metoclopramide in Infants, Children, and Adolescents
Shufan Ge, Susan R Mendley, Jacqueline G Gerhart, et al.
Page
of 3